COMPARISON OF ALTEPLASE DOSING STRATEGIES IN PATIENTS UNDERGOING CATHETER DIRECTED THROMBOLYSIS FOR ACUTE PULMONARY EMBOLISM | Journal of the American College of Cardiology
PulmCrit- Submassive PE 2017: Getting 'em off the cliff
Difficulties of Managing Submassive and Massive Pulmonary Embolism in the Era of COVID-19 - ScienceDirect
Thrombolytic Therapy During Cardiac Arrest for Suspected Massive Pulmonary Embolism Guideline
Systemic Thrombolytic Therapy for Massive and Submassive Pulmonary Embolism - Lauren A. Igneri, John M. Hammer, 2020
Comparison of the use of alteplase infusions with bolus-dose alteplase... | Download Scientific Diagram
Frontiers | Tenecteplase in Pulmonary Embolism Patients: A Meta-Analysis and Systematic Review
Actilyse Full Prescribing Information, Dosage & Side Effects | MIMS Hong Kong
Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial - The Lancet Neurology
Thrombolytics for PE in Cardiac Arrest – CriticalCareNow
Percutaneous treatment options for acute pulmonary embolism: a clinical consensus statement by the ESC Working Group on Pulmonary Circulation and Right Ventricular Function and the European Association of Percutaneous Cardiovascular Interventions -